Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Evaluation of criteria for clinical control in a prospective, international, multicenter study of patients with COPD.

Miravitlles M, Sliwinski P, Rhee CK, Costello RW, Carter V, Tan J, Lapperre TS, Alcazar B, Gouder C, Esquinas C, García-Rivero JL, Kemppinen A, Tee A, Roman-Rodríguez M, Soler-Cataluña JJ, Price DB.

Respir Med. 2018 Mar;136:8-14. doi: 10.1016/j.rmed.2018.01.019. Epub 2018 Jan 31.

PMID:
29501251
2.

Mucus hypersecretion in asthma is associated with rhinosinusitis, polyps and exacerbations.

Martínez-Rivera C, Crespo A, Pinedo-Sierra C, García-Rivero JL, Pallarés-Sanmartín A, Marina-Malanda N, Pascual-Erquicia S, Padilla A, Mayoralas-Alises S, Plaza V, López-Viña A, Picado C.

Respir Med. 2018 Feb;135:22-28. doi: 10.1016/j.rmed.2017.12.013. Epub 2018 Jan 3.

PMID:
29414449
3.

Algorithm for the management of asthma in pregnant women: a protocol to optimize processes in healthcare.

Martinez-Moragón E, Romero-Falcón A, García-Rivero JL.

Expert Rev Respir Med. 2017 Dec;11(12):1003-1012. doi: 10.1080/17476348.2017.1391094. Epub 2017 Oct 23.

PMID:
29016232
4.

Impact of Asthma on the Sexual Functioning of Patients. A Case-Control Study.

Soto Campos JG, Rojas Villegas J, Padilla Galo A, Marina Malanda N, Garcia Rivero JL, Pinedo Sierra C, Garcia Salmones M, Cabrera Galán C, Segura Molina E, Plaza V, Pascual Erquicia S; Grupo Emergente de Asma (GEA) del Área de Asma de la SEPAR.

Arch Bronconeumol. 2017 Dec;53(12):667-674. doi: 10.1016/j.arbres.2017.05.011. Epub 2017 Jun 21. English, Spanish.

5.

GOLD 2017: The Spanish Perspective.

Sobradillo Ecenarro P, García-Rivero JL.

Arch Bronconeumol. 2017 Nov;53(11):603-604. doi: 10.1016/j.arbres.2017.05.013. Epub 2017 Jun 16. English, Spanish. No abstract available.

6.

Estimating the economic consequences of an increased medication adherence due to a potential improvement in the inhaler technique with Spiromax® compared with Turbuhaler® in patients with moderate-to-severe chronic obstructive pulmonary disease in Spain.

Darbà J, Ramírez G, García-Rivero JL, Mayoralas S, Pascual JF, Vargas D, Bijedic A.

Clinicoecon Outcomes Res. 2017 Feb 10;9:127-137. doi: 10.2147/CEOR.S125301. eCollection 2017.

7.

Risk Factors of Poor Outcomes after Admission for a COPD Exacerbation: Multivariate Logistic Predictive Models.

García-Rivero JL, Esquinas C, Barrecheguren M, Bonnin-Vilaplana M, García-Sidro P, Herrejón A, Martinez-Rivera C, Malo de Molina R, Marcos PJ, Mayoralas S, Naval E, Ros JA, Valle M, Miravitlles M.

COPD. 2017 Apr;14(2):164-169. doi: 10.1080/15412555.2016.1260538. Epub 2016 Dec 16.

PMID:
27983876
8.

[Reliability of a chronic obstructive pulmonary disease diagnosis register in Primary Care].

Garrastazu R, García-Rivero JL, Ruiz-Nuñez M, Helguera JM, Arenal S, Bonnardeux C, León C, Miravitlles M, Santibañez M.

Semergen. 2017 Jul - Aug;43(5):364-374. doi: 10.1016/j.semerg.2016.06.001. Epub 2016 Sep 28. Spanish.

PMID:
27692678
9.
10.

Independent effect of prior exacerbation frequency and disease severity on the risk of future exacerbations of COPD: a retrospective cohort study.

Margüello MS, Garrastazu R, Ruiz-Nuñez M, Helguera JM, Arenal S, Bonnardeux C, León C, Miravitlles M, García-Rivero JL.

NPJ Prim Care Respir Med. 2016 Sep 8;26:16046. doi: 10.1038/npjpcrm.2016.46.

11.

Predictors of Hospitalized Exacerbations and Mortality in Chronic Obstructive Pulmonary Disease.

Santibáñez M, Garrastazu R, Ruiz-Nuñez M, Helguera JM, Arenal S, Bonnardeux C, León C, García-Rivero JL.

PLoS One. 2016 Jun 30;11(6):e0158727. doi: 10.1371/journal.pone.0158727. eCollection 2016.

12.

A cross-sectional study to assess inhalation device handling and patient satisfaction in COPD.

Miravitlles M, Montero-Caballero J, Richard F, Santos S, Garcia-Rivero JL, Ortega F, Ribera X.

Int J Chron Obstruct Pulmon Dis. 2016 Feb 26;11:407-15. doi: 10.2147/COPD.S91118. eCollection 2016.

13.

The CAT (COPD Assessment Test) questionnaire as a predictor of the evolution of severe COPD exacerbations.

García-Sidro P, Naval E, Martinez Rivera C, Bonnin-Vilaplana M, Garcia-Rivero JL, Herrejón A, Malo de Molina R, Marcos PJ, Mayoralas-Alises S, Ros JA, Valle M, Esquinas C, Barrecheguren M, Miravitlles M.

Respir Med. 2015 Dec;109(12):1546-52. doi: 10.1016/j.rmed.2015.10.011. Epub 2015 Oct 27.

14.

Prevalence of Influenza Vaccination in Chronic Obstructive Pulmonary Disease Patients and Impact on the Risk of Severe Exacerbations.

Garrastazu R, García-Rivero JL, Ruiz M, Helguera JM, Arenal S, Bonnardeux C, León C, Llorca J, Santibañez M.

Arch Bronconeumol. 2016 Feb;52(2):88-95. doi: 10.1016/j.arbres.2015.09.001. Epub 2015 Oct 29. English, Spanish.

15.

Cortico-dependent Asthma: Our Clinical Experience.

Pérez de Llano LA, García Rivero JL, Pallares A, Mengual N, Golpe R.

Arch Bronconeumol. 2015 Dec;51(12):660-1. doi: 10.1016/j.arbres.2015.02.017. Epub 2015 Apr 21. English, Spanish. No abstract available.

16.

[Alkaptonuria & ochronosis].

MANGUEL M, GARCIA RIVERO J, PALLAVICINI O.

Prensa Med Argent. 1958 Feb 7;45(6):577-82. Spanish. No abstract available.

PMID:
13578839

Supplemental Content

Loading ...
Support Center